News - Novartis, Production


Current filters:


Popular Filters

BNDES invests 804 million real in Novartis' new Brazil biotechnology unit

BNDES invests 804 million real in Novartis' new Brazil biotechnology unit


The Brazilian Development Bank will finance 804 million real ($342 million) for the construction of a…

BexseroBiotechnologyBrazilFinancialNovartisProductionSouth AmericaVaccines

FDA warns Novartis on Austrian generic manufacturing plant cGMP failures


The US Food and Drug Administration has written to Joseph Jimenez, chief executive of Swiss drug major…

Ebewe PharmaGenericsNovartisProductionRegulationSandoz

Switzerland's Lonza involvement in South Africa pharma project in doubt


The South Africa government is expected to publish a request for information from potential international,…

Anti-viralsGenericsLonzaNovartisProductionRest of the World

Sagent Pharma launches generic Zometa in USA; amends supply deal with Actavis


Privately-held US specialty pharmaceutical company Sagent Pharmaceuticals has announced the approval…

ActavisGenericsMarkets & MarketingNorth AmericaNovartisOncologyProductionSagent PharmaceuticalsZometa

FDA approves Novartis' Flucelvax, first seasonal flu vaccine using cell culture technology


The US Food and Drug Administration yesterday approved Swiss drug major Novartis' (NOVN: VX) Flucelvax,…

FlucelvaxNorth AmericaNovartisPharmaceuticalProductionRegulationVaccines

Playing ball with Russia in the pharma sector


Commenting on last week's announcement that Takeda Pharmaceuticals (TYO: 4502) had completed its $96…

EuropeNovartisPharmaceuticalPoliticsProductionTakeda PharmaceuticalsTeva Pharmaceutical Industries

News briefs: Drug majors eyeing Strides Arcolab unit; Astellas invests in oncology facility


Leading drug multinationals, including global behemoth Pfizer (NYSE: PFE) and Swiss major Novartis (NOVN:…

Agila SpecialitesAstellas PharmaGenericsHospiraMergers & AcquisitionsNovartisPfizerPharmaceuticalProductionStrides Arcolab

Back to top